Kim and co-workers report systematical studies with methylammonium chloride (MACl) in formamidinium lead iodide (FAPbI 3 )-based perovskite thin films. The MACl addition could induce the intermediate phase with pure a-phase without annealing, effectively stabilizing the structure, only through cationic site substitution. The film quality can be significantly improved, exhibiting a 63 increase in grain size, a 33 increase in phase crystallinity, and a 4.33 increase in photoluminescence lifetime. The resulting optimized solar cells achieved a peakscan efficiency of above 24%.

Further improvement and stabilization of perovskite solar cell (PSC) performance are essential to achieve the commercial viability of next-generation photovoltaics. Considering the benefits of fluorination to conjugated materials for energy levels, hydrophobicity, and noncovalent interactions, two fluorinated isomeric analogs of the well-known hole-transporting material (HTM) Spiro-OMeTAD are developed and used as HTMs in PSCs. The structure–property relationship induced by constitutional isomerism is investigated through experimental, atomistic, and theoretical analyses, and the fabricated PSCs feature high efficiency up to 24.82% (certified at 24.64% with 0.3-volt voltage loss), along with long-term stability in wet conditions without encapsulation (87% efficiency retention after 500 hours). We also achieve an efficiency of 22.31% in the large-area cell.

Previously, we reported the molecular cloning of cDNA for the prophenoloxidase activating factor‐I (PPAF‐I) that encoded a member of the serine proteinase group with a disulfide‐knotted motif at the N‐terminus and a trypsin‐like catalytic domain at the C‐terminus [Lee, S.Y., Cho, M.Y., Hyun, J.H., Lee, K.M., Homma, K.I., Natori, S., Kawabata, S.I., Iwanaga, S. & Lee, B.L. (1998) Eur. J. Biochem. 257, 615–621]. PPAF‐I is directly involved in the activation of pro‐phenoloxidase (pro‐PO) by limited proteolysis and the overall structure is highly similar to that of Drosophila easter serine protease, an essential serine protease zymogen for pattern formation in normal embryonic development. Here, we report purification and molecular cloning of cDNA for another 45‐kDa novel PPAF from the hemocyte lysate of Holotrichia diomphalia larvae. The gene encodes a serine proteinase homologue consisting of 415 amino‐acid residues with a molecular mass of 45 256 Da. The overall structure of the 45‐kDa protein is similar to that of masquerade, a serine proteinase homologue expressed during embryogenesis, larval, and pupal development in Drosophila melanogaster. The 45‐kDa protein contained a trypsin‐like serine proteinase domain at the C‐terminus, except for the substitution of Ser of the active site triad to Gly and had a disulfide‐knotted domain at the N‐terminus. A highly similar 45‐kDa serine proteinase homologue was also cloned from the larval cDNA library of another coleopteran, Tenebrio molitor. By in vitro reconstitution experiments, we found that the purified 45‐kDa serine proteinase homologue, the purified active PPAF‐I and the purified pro‐PO were necessary for expressing phenoloxidase activity in the Holotrichia pro‐PO system. However, incubation of pro‐PO with either PPAF‐I or 45‐kDa protein, no phenoloxidase activity was observed. Interestingly, when the 45‐kDa protein was incubated with PPAF‐I and pro‐PO in the absence, but not in the presence of Ca2+, the 45‐kDa protein was cleaved to a 35‐kDa protein. RNA blot hybridization revealed that expression of the 45‐kDa protein was increased in the Holotrichia hemolymph after Escherichia coli challenge.

System L is a major nutrient transport system responsible for the Na(+)-independent transport of large neutral amino acids including several essential amino acids. In malignant tumors, a system L transporter L-type amino acid transporter 1 (LAT1) is up-regulated to support tumor cell growth. LAT1 is also essential for the permeation of amino acids and amino acid-related drugs through the blood-brain barrier. To search for in vitro assay systems to examine the interaction of chemical compounds with LAT1, we have investigated the expression of system L transporters and the properties of [14C]L-leucine transport in T24 human bladder carcinoma cells. Northern blot, real-time quantitative PCR and immunofluorescence analyses have reveled that T24 cells express LAT1 in the plasma membrane together with its associating protein 4F2hc, whereas T24 cells do not express the other system L isoform LAT2. The uptake of [14C]L-leucine by T24 cells is Na(+)-independent and almost completely inhibited by system L selective inhibitor BCH. The profiles of the inhibition of [14C]L-leucine uptake by amino acids and amino acid-related compounds in T24 cells are comparable with those for the LAT1 expressed in Xenopus oocytes. The majority of [14C]L-leucine uptake is, therefore, mediated by LAT1 in T24 cells. Consistent with LAT1 in Xenopus oocytes, the efflux of preloaded [14C]L-leucine is induced by extracellularly applied substrates of LAT1 in T24 cells. This efflux measurement has been proven to be more sensitive than that in Xenopus oocytes, because triiodothyronine, thyroxine and melphalan were able to induce the efflux of preloaded [14C]L-leucine in T24 cells, which was not detected for Xenopus oocyte expression system. T24 cell is, therefore, proposed to be an excellent tool to examine the interaction of chemical compounds with LAT1.